Skip to content
GenoLensGenoLens

MTAP

Chr 9p21.3

methylthioadenosine phosphorylase

Aliases:
MSAP, c86fus
MANE:
ENST00000644715.2

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Sarcoma cancer susceptibility

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Sarcoma susceptibility

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Childhood solid tumours

  • Monogenic hearing loss

  • Skeletal dysplasia

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • diaphyseal medullary stenosis-bone malignancy syndrome

    0.69
  • Diaphyseal medullary stenosis - bone malignancy

    0.62
  • melanoma

    0.48
  • cutaneous melanoma

    0.48
  • coronary artery disorder

    0.44
  • lung adenocarcinoma

    0.41
  • coronary atherosclerosis

    0.40
  • non-small cell lung carcinoma

    0.37
  • melanocytic nevus

    0.35
  • skin cancer

    0.33

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

S-methyl-5'-thioadenosine phosphorylase

Catalyzes the phosphorolytic cleavage of S-methyl-5'-thioadenosine (MTA) to adenine and 5-methylthioribose1-phosphate (PubMed:3091600, PubMed:8687427, PubMed:10404592). Involved in the breakdown of MTA, a major by-product of polyamine biosynthesis (PubMed:3091600, PubMed:8687427, PubMed:10404592). Responsible for the first step in the methionine salvage pathway after MTA has been generated from S-adenosylmethionine (PubMed:3091600, PubMed:8687427, PubMed:10404592). Has broad substrate specificity with 6-aminopurine nucleosides as preferred substrates (PubMed:10404592)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.